Obesity Surgery Devices Market by type (Gastric Balloons, Gastric Bands and Stapling Devices)
Industry: Healthcare
Published Date: February-2023
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 250
Report ID: PMRREP2894
The global revenue from the Obesity Surgery Devices Market was approximately US$ 1.64 Billion in 2022, with the global market expected to grow at a CAGR of 6.4% to reach a valuation of around US$ 3.23 Billion by the end of 2033.
|
Market Size (2023) |
US$ 1.74 Billion |
|
Projected Market Value (2033) |
US$ 3.23 Billion |
|
Global Market Growth Rate (2023 to 2033) |
6.4% CAGR |
|
Market Share of Top 5 Countries |
54.2% |
As assessed by Persistence Market Research, stapling devices held a market share of around 90.2% in the global market, in 2022. The global obesity surgery devices market holds nearly 10.6% revenue share of the global surgical equipment market valued at US$ 15.5 Billion in 2022.
The global market recorded a historic CAGR of 4.6% in the last 5 years from 2017 to 2022.
It is anticipated that rising obesity rates would encourage market growth. Numerous nations also deal with a significant burden of obesity-related ailments, primarily in children, including diabetes, hypertension, and cardiovascular diseases. The rapid urbanisation and economic growth of Asian nations, as well as a growing preference for fast, processed junk food, are all factors in the region's expanding disease burden.
Consistent technical development is therefore creating profitable chances for industry penetration in developed economies. Further, some surgical tools that have fewer negative side effects, such as less blood loss and shorter operating times, along with higher efficacy and better patient outcomes, are expected to improve market prospects.
The global market is likely to show high growth over the coming years at a CAGR of 6.4% and reach a global market size of 3.23 Billion by 2033.
“Increasing incidence of obesity in children and adults, and spending on healthcare and diseases linked to obesity is aiding market growth.”
Increasing prevalence of obesity among children as well as adults over the globe has become a serious health issue. This will remain a key factor fuelling the demand for obesity surgery devices in the global market. The major reason for the rise of obesity among children in recent times is bad eating pattern and lower physical activity.
For instance, by 2030, one in ten children worldwide, or more than 27 million children, are expected to be obese in India, according to Unicef's World Obesity Atlas for 2022. Accordingly, the rising prevalence of obesity is driving the global obesity surgery device market.
As out-of-pocket healthcare costs go up in both emerging and developed nations, it is anticipated that the use of obesity management strategies and treatments would increase. Both established and developing economies are seeing increases in per capita healthcare spending, which is expected to encourage the growth of high-quality patient-care treatment options.
The market for obesity surgery devices is anticipated to be driven by growing awareness within overweight individuals living in developing countries about the potential negative consequences of obesity, like diabetes, cancers, CVDs, and stroke. For instance, Obesity has an impact on the heart, kidneys, liver, ligaments, and reproductive system, according to WHO.
Numerous non-communicable diseases (NCDs), including type-2 diabetes, cardiovascular, hypertension, stroke, different types of cancer, and mental health problems are caused by it. Further, the minimally invasive procedure for the weight loss will promote market expansion.
Many governments are putting forward campaigns to raise awareness of obesity and are implementing different action plans to reduce obesity. For instance, the LaparoObeso Centre has launched a project with support from the Maharashtra State Government to reach individuals in the most remote areas in India with accurate data about obesity and diabetes.
The Obesity Prevention and Control Section of the Chinese Nutrition Society (OPCS-CNS) has closely worked with other groups to introduce a string of awareness campaigns during the World Obesity Day 2022 in order to encourage society throughout China to pay close attention to the obesity crisis and consider taking more effective measures.
“High production cost and limited financial support for surgery”
The market expansion for obesity surgery devices may be hampered by the high cost of research and development of obesity devices as well as by the lack of financial assistance. A significant financial outlay is also added by the prolonged growing period necessary for research and development activities and the inclusion of clinical trials needed to assess medications.
Therefore, in light of the current situation, producers must exercise caution and ensure that their investments are made in markets that offer higher returns. The hazards and restrictions brought on by the expensive medical devices required to treat obesity can stifle the expansion of the global market.
The global market for obesity surgery devices may experience a slowdown in growth due to the high cost of surgical procedures such gastric sleeve surgery, gastric bypass surgery, and adjustable gastric banding treatment.
Why is the United States Market Booming?
“Increasing obesity patients, growing FDA approvals to curb obesity may rise the demand for obesity surgery devices.”
The United States accounted for around 31.8% market share in the global obesity medical device market in 2022.
According to United States National Health Statistics reports released in June 2021, the prevalence of obesity among adults 20 and older was 41.9%, and severe obesity was 9.2%. The market for bariatric surgery in the United States is anticipated to be driven by the rise in obesity prevalence among the population. Further, the presence of several market participants and FDA product approvals in the nation are anticipated to boost market expansion throughout the projection period.
For instance, the Gastro Intestinal Balloon Indicator (GIBI HD) calibration tube from ReShape Lifesciences has received 510(k) clearance from the United States Food and Drug Administration (FDA) for use in gastric and bariatric surgery operations.
Will the Germany Be a Lucrative Market for Obesity Surgery Device Market?
“Rise in obese population in the country”
The Germany market held around 7.0% market share of the global market in 2022.
The market is expanding as a result of a growing number of causes, including the increased incidence of type 2 diabetes and heart disease. In Germany, 53.5% of adults were overweight, while men being more obese than women, according to “Overweight and obesity among adults in Germany - Results from GEDA 2019/2020-EHIS. J Health Monit. 2022”, 53.5% of adults in Germany are overweight. In Germany, the prevalence of overweight and obesity rose with age in both men and women.
Will the United Kingdom Be a Lucrative Market for Obesity Surgery Devices?
“Government initiatives for appropriate management of obese patients.”
The United Kingdom market held around 5.9% market share of the global market in 2022.
For instance, the United Kingdom government changed its policies in 2021 to provide treatment for obese individuals after bariatric surgery. The policies by the United Kingdom Department of Health and Social Care mandate appropriate operational procedures for the planning, evaluation, and maintenance of the risks from manual handling for the care and therapy of bariatric patients and design buildings and transportation to provide accommodation to the obese patients in a safe manner with convenience and integrity.
How is China Emerging as a Prominent Market?
“Series of policies, recommendations and guidelines related to obesity intervention is promoting the market in China”
China held a market share of about 5.2% of the global market in 2022.
China has a large prevalence of obesity and overweight. In China, 20% of children and adolescents and more than 50% of adults are overweight or obese, as per “Obesity intervention efforts in China and the 2022 World Obesity Day, Global Health Journal, Volume 6, Issue 3, 2022”. China issued a number of policies to address this.
To efficiently enhance the control and prevention of obesity among children and adolescents, the National Health Commission of the People's Republic of China (China NHC), the Ministry of Education, the General Administration of Sport, and other three central government departments jointly developed The “Implementation Plan for Prevention efforts of Obesity among Children and Adolescents” in 2020. The China NHC’s Bureau of Disease Control and Prevention in 2021 published the guidelines for prevention and control of overweight and obesity among Chinese population.
Which Medical Device is Driving Demand within the Global Market?
“Growing applications of stapling devices in obesity surgeries.”
The stapling devices held around 90.2% share of the total market in 2022.
During surgery, staple line reinforcement may lower morbidity or lower the possibility of bleeding and staple line leaks. Devices for surgical stapling enable stomach compartmentalization without total trans-section. Surgical stapling tools are becoming more and more crucial in operations, particularly challenging ones like weight loss surgery. This automated medical equipment has developed in response to several advancements in medical operations during the past few years.
The use of surgical stapling devices facilitates the development of new surgical techniques, the alteration of existing procedures, and the enhancement of clinical results. Advanced surgical stapling devices are widely adopted due to the increasing demand for less invasive procedures across the globe.
Which End User is Widely Adopted?
“High quality care and treatment is aiding product adoption hospitals.”
Hospitals held around 55.7% share of the total market in 2022.
Patients are being drawn to have surgery in hospitals due to the utilisation of modern technology for surgeries and improved patient care, as well as an increase in robotic surgeries with precise treatments. As a result, hospitals have a strong demand for obesity surgical equipment.
The businesses' main priorities are to increase production volume, improve their line of surgery devices, introduce advanced features, and introduce new products. For accelerated and improved manufacturing, several businesses have purchased and worked with regional and global players.
Some key instances of development include:
|
Attribute |
Details |
|
Forecast Period |
2023 to 2033 |
|
Historical Data Available for |
2017 to 2022 |
|
Market Analysis |
|
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Covered |
|
|
Report Coverage |
|
|
Customization & Pricing |
Available upon Request |
Medical Devices/ Implants:
End User:
Region:
To know more about delivery timeline for this report Contact Sales
The global market is currently valued at around US$ 1.64 Billion in 2022.
Sales of the market are set to witness growth at a CAGR of 6.4% and be valued at around US$ 3.23 Billion by 2033.
Demand for the global market increased at a 4.6% CAGR from 2017 to 2022.
The U.S., Germany, U.K., China, and Japan account for most demand within the market, currently holding around 54.2% market share.
The U.S. accounts for around 31.8% share of the North American market in 2022.
North America accounts for around 35.5% share of the global market in 2022.
The China market held a share of about 5.2% in the global obesity surgery devices market in 2022.
The German obesity surgery devices market held a share of around 7.0% in the global market, in 2022.
The Japan market held a share of around 4.3% in the global market, in 2022.
The obesity surgery devices market in U.K. held around 5.9% share in the global market 2022.
